- Vitae ranked second overall in life sciences industry; highest-ranked U.S. company
- Survey measured responses of more than 200 companies worldwide
Fort Washington, PA, June 12, 2013 – Vitae Pharmaceuticals, Inc., a clinical‐stage
biopharmaceutical company discovering and developing novel, small molecule, best‐in‐class
compounds, today announced that the company ranked second among life sciences companies
in the 11th annual Best Places to Work in Industry survey conducted by The Scientist. Vitae is
the highest-ranked U.S. company on the list, which is based on a detailed survey taken by
scientists at life sciences companies and research institutions.
“Vitae’s success in creating rapid discovery breakthroughs for important drug targets is driven
by the powerful combination of a highly talented scientific team, a proprietary structure-based
design technology, a shared value system and a truly amazing culture,” said Jeff Hatfield,
Vitae’s President and CEO. “Vitae’s team-based culture leads to a stimulating, fast and uniquely
integrated work environment. Vitae takes pride in, and is at its best, taking on the biggest and
most valuable discovery targets, including our rapidly advancing program for RORgt in
The web-based survey included responses from 240 companies worldwide. Respondents were
asked to assess their working environment according to 43 criteria in eight categories including
research environment, management, integrity, job satisfaction, communications, and training
and development. The overall rankings were based on the average score per company across
The full article with detailed survey results and methodology can be found in the June issue of
The Scientist and is available online at www.the-scientist.com.
About The Scientist
The Scientist,the award-winning magazine of the life sciences, has informed and entertained
life science professionals around the world for more than 20 years. We provide print and online
coverage of the latest developments in the life sciences including trends in research, new
technology, news, business and careers. We reach the leading researchers in academia and
industry who are interested in maintaining a broad view of the life sciences by reading insightful
articles that are current, concise, accurate and entertaining.
For more information about The Scientist, visit www.the-scientist.com.
About Vitae Pharmaceuticals
Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company discovering and
developing a portfolio of novel, small molecule, best-in-class compounds that address important
disease areas, including chronic kidney disease, diabetes, Alzheimer’s disease, and
inflammation / immunology.
Vitae excels at structure-based drug discovery and combines a proprietary technical platform
with the insight of world class scientists to advance best-in-class compounds for high value,
hard-to-drug targets. The accuracy and speed of Vitae’s drug discovery platform has enabled
the company to discover and advance attractive compounds in multiple therapeutics areas in a
rapid and highly capital efficient manner.
For additional information, please visit the company’s website at www.vitaepharma.com.